PacBio Appoints Mark Van Oene as President and CEO

Pacific Biosciences of California, Inc. announced the appointment of Mark Van Oene as its new President and Chief Executive Officer, effective August 5, 2026. Mr. Van Oene, who previously served as Chief Operating Officer, will also join the company's Board of Directors. He succeeds Christian Henry, who stepped down after six years but will remain on the Board and serve as a business advisor through the end of 2026 to ensure a smooth transition. The Board highlighted Mr. Van Oene's deep experience in scaling life sciences businesses and his contributions to PacBio's operational execution and strategic initiatives, particularly in AI-related product improvements and clinical applications.